Development of Pharmacokinetics Model in Pregnancy Women and Fetus

N/ACompletedNCT01916330

Seoul National University Hospital96 enrolled

Overview

Pharmacokinetics analysis and development of pharmacokinetics model in pregnancy women and fetus

Study Type

OBSERVATIONAL

Enrollment

Conditions

Preterm Labor Preterm Premature Rupture of Membrane (PPROM)

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 20 \<= age \< 50 * pregnant women who were administered intramuscular dexamethasone (ex) preterm labor) * pregnant women who were administered PO clarithromycin (ex) PPROM/intrauterine infection or inflammation) Exclusion Criteria: * who deny the study entrance * who administered study drug before transfer to tertiary hospital

Locations (1)

Seoul National University Hospital

Seoul, South Korea

Outcomes

Primary Outcomes

Analysis of drug concentration

drug (dexamethasone, clarithromycin)

Time frame: Day 1 after delivery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.